Tharimmune (THAR) Institutional Ownership $1.90 +0.04 (+1.99%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.88 -0.02 (-1.05%) As of 02/21/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tharimmune (NASDAQ:THAR)CurrentInstitutional OwnershipPercentage1.16%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$101.96KNumber ofInstitutional Sellers(last 12 months)0 Get THAR Insider Trade Alerts Want to know when executives and insiders are buying or selling Tharimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Tharimmune Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025 Virtu Financial LLC21,371$44K0.0%N/A1.107% 11/6/2024 Curi RMB Capital LLC23,620$59K0.0%N/A2.056% (Data available from 1/1/2016 forward) THAR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THAR shares? During the previous two years, the following institutional investors and hedge funds held shares of Tharimmune shares: Curi RMB Capital LLC ($59K), Virtu Financial LLC ($44K).Learn more on THAR's institutional investors. What percentage of Tharimmune stock is owned by institutional investors? 1.16% of Tharimmune stock is owned by institutional investors. Learn more on THAR's institutional investor holdings. Which institutional investors have been buying Tharimmune stock? The following institutional investors have purchased Tharimmune stock in the last 24 months: Curi RMB Capital LLC ($23.62K), and Virtu Financial LLC ($21.37K). How much institutional buying is happening at Tharimmune? Institutional investors have bought a total of 44,991 shares in the last 24 months. This purchase volume represents approximately $101.96K in transactions. Related Companies HCW Biologics Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership GeoVax Labs Institutional Ownership Minerva Neurosciences Institutional Ownership Trinity Biotech Institutional Ownership Cingulate Institutional Ownership Cellectar Biosciences Institutional Ownership Imunon Institutional Ownership CervoMed Institutional Ownership Biomerica Institutional Ownership This page (NASDAQ:THAR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THAR Stock Alerts